Image for post
Image for post

Global mass medias have reported the good news about the first coronavirus vaccine developed by Moderna Therapeutics, a Cambridge-based biotech company. The company also became the first to start human trial testing of its novel vaccine. We are pleased to find a strong “Caucasian connection” at the very frontline of global struggle against COVID-19: Moderna’s founding father and chairman, Dr. Noubar Afeyan, is also co-founder of the Foundation for Armenian Science and Technology (FAST), and an active participant of other Armenian projects related to science.

On March 28 Dr. Noubar Afeyan participated in the online webinar “COVID-19: Challenging General Fear”. Caucasian Journal is pleased to present the video of his presentation. The webinar, moderated by well-known entrepreneur and venture philanthropist Ruben Vardanyan, was co-organized by a number of Armenia-based organizations including Armenia2041.org, IDeA Foundation, Aurora Humanitarian Initiative, UWC Dilijan College, Foundation for Armenian Science and Technology (FAST).

Below is the full version of webinar “COVID-19: Challenging General Fear”. The speakers include:

Read more »

Caucasian Journal covers what matters to people in this region of the world: www.CaucasianJournal.org https://www.facebook.com/CaucasianJournal.org/

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store